comparison of cystone & hydrochlorothiazide in treatment of kidney stone

study of efficacy &side effects of oral cystone & hydrochlorothiazide in treatment of patients older than 15 years old suffering from kidney& ureteral calculi

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20081011001323N15

Enrollment

Registered

2018-03-14

Start date

2018-01-21

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calculus of kidney and ureter. Calculus of kidney with calculus of ureter

Interventions

Intervention 1: Intervention group: Cystone Tablets take 2 tablets with one glass of water every 12 hours for one month. Intervention 2: Control group: Hydrochlorothiazide Tablets 25 miligram every 1

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: age more than15 years old suffering from renal or upper ureteral stone less than 10 millimeter Having informed consent form

Exclusion criteria

Exclusion criteria: Uncontrolled coagulopathy Azotemia Pregnancy Presence of active urinary tract infection Allergy to medical or herbal drugs Severe cardiovascular or pulmonary disease

Design outcomes

Primary

Measure	Time frame
Passage of renal and upper ureteral stones sized 5-10 milimeter. Timepoint: Two weeks and one month after start of treatment. Method of measurement: Taking KUB and Ultrasonography and report of patients.	—

Secondary

Measure	Time frame
Development of side effects. Timepoint: from start of treatment to one month later. Method of measurement: according to history and physical exam and patient report.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSadrollah Mehrabi

Yasouj University of Medical Sciences

dr.mehrabi@yums.ac.ir+98 74 3334 6070

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026